How many investments has ARCHIMED Japan made?

ARCHIMED Japan has 59 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.

What stage does ARCHIMED Japan invest at?

ARCHIMED Japan invests at the Growth, Late Stage stages.

What is ARCHIMED Japan's typical check size?

ARCHIMED Japan typically writes checks of $10.8M – $1.1B.

Where is ARCHIMED Japan located?

ARCHIMED Japan is headquartered in Lyon, FR.

Does ARCHIMED Japan lead rounds?

Yes, ARCHIMED Japan leads investment rounds.

ARCHIMED Japan

Private equity

Lyon · Growth–Late Stage · 22 people tracked

Also known as ARCHIMED Japan G.K. · ArchiMed Pte. Ltd. · ARCHIMED SAS

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into ARCHIMED Japan

1,854 people in our graph share verified history with the ARCHIMED Japan team — schools, employers, funds. One of them is your warm intro.

Doug Bandunlockedknows Justin Bateman · together at Teneo (overlapped)

knows the team · via Teneo

knows the team · via BC Partners

×2knows the team · via Baxter Healthcare Corporation

×2knows the team · via Brown Brothers Harriman

knows the team · via BNP Paribas Corporate and Institutional Banking

✨ Fox Verdict

Investment thesis

ARCHIMED specializes exclusively in the healthcare industries, funding, supporting, and scaling companies whose activities improve health outcomes at all levels. Founded by healthcare professionals, the firm structures its team roughly evenly across finance, scientific, and operational expertise. It pursues leveraged buyouts globally through dedicated funds such as its MED Platform vehicles, targeting biopharmaceuticals, life science tools and services, healthcare IT, medtech, and related segments. ARCHIMED emphasizes strategic partnership with entrepreneurs and former CEOs, aiming to deliver superior returns to investors and to society while driving meaningful growth in its portfolio companies.

Invests inBiotech Digital Health Healthtech Longevity Medical DevicesSector AgnosticWellness & Fitness Asia-Pacific Europe Global Japan Lyon New York North America Singapore Singapore

Source: firm website, verified Sep 26, 2026.

Stage

Growth–Late Stage

Check

$10.8M – $1.1B

Lyon, FR

Leads rounds

Leads

Instruments

Equity

Founded

2008

Last 12 months

1 investment

Private fund assets

$7.6B

Tracked investments

IPOs

Team · 22 people

from the firm's website

Denis Ribon· Chairman, Managing Partnerin

Denis Ribon is Chairman and Managing Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America. The firm combines investment, medical, scientific, and operational expertise to partner with healthcare enterprises on growth and value creation.

André-Michel Ballester· Managing Partner· New York, New York, United Statesin

André-Michel Ballester is Managing Partner at ARCHIMED, a global private equity firm specializing in healthcare investments. He leads a team that provides investment, medical, scientific, and operational expertise to healthcare enterprises in Europe and North America.

Angie Kim· Managing Director· Seoul, Seoul, South Koreain

Angie Kim is a Managing Director at ARCHIMED with 29 years of experience in the healthcare industry, including roles in pharmaceuticals, medical devices, medical aesthetics, and analytical instruments. Her background spans commercial operations, corporate strategy, strategic partnerships, market access, and general management across country, regional, and global headquarters. She serves as a board member in the healthcare and life science sectors.

Anthony Farias· Partner· New York, New York, United Statesin

Anthony Farias is a partner at ARCHIMED, a global private equity firm specializing in healthcare sector investments across Europe and North America. He works within a team that integrates investment, medical, scientific, and operational expertise to support healthcare enterprises.

Antoine Faguer· Partner· Paris, Île-de-France, Francein

Antoine Faguer is President of Lepto and Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America.

Baptiste Mélinon· Partner, Head of Investor Relations· Francein

Baptiste Mélinon is a Partner and Head of Investor Relations at ARCHIMED, a global private equity firm specializing in healthcare investments. At ARCHIMED, he works within an international team that provides strategic and financial partnership to healthcare enterprises in Europe and North America, leveraging combined expertise in investment, medical, scientific, and operational domains.

Benoît Varichon· Partner· Lyon, Auvergne-Rhône-Alpes, Francein

Benoît Varichon is a Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America. At ARCHIMED, he works within a team that combines investment, medical, scientific, and operational expertise to support healthcare enterprises.

Carlos Alonso· Partner· New York City Metropolitan Areain

Carlos Alonso is a partner at ARCHIMED and board member of Irrimax Corporation with over 35 years of executive experience in healthcare, industrial equipment, engineering, and chemicals across multinational organizations including Hill-Rom Holdings, Esaote Group, Esteve Pharmaceuticals, Baxter International, and Dentsply Sirona. He currently serves as chairman of the board for Direct Healthcare Group and Cardioline SpA, and has held board positions at Esaote Group and the University of Miami Business School's Health Sector Management & Policy advisory board. His background encompasses mergers and acquisitions, general management, product innovation, and international business operations across multiple countries.

Giuseppe Accogli· Partner· Francein

Giuseppe Accogli is a Partner at ARCHIMED, a global private equity firm specializing in healthcare investments. He works with an international team that provides investment, medical, scientific, and operational expertise to healthcare enterprises worldwide.

Jean-Yves Desmottes· Partner· Greater Lyon Areain

Jean-Yves Desmottes is a Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America. He is also co-founder of Minthacare. At ARCHIMED, he works with a team combining investment, medical, scientific, and operational expertise to support healthcare enterprises.

Justin Bateman· Partner· New York, New York, United Statesin

Partner at ARCHIMED who commented on the firm's acquisition of Esperion Therapeutics.

Loïc Kubitza· Partner· Francein

Loïc Kubitza is a Partner at ArchiMed, a global private equity firm specializing in healthcare investments across Europe and North America. He works within a multidisciplinary team that provides investment, medical, scientific, and operational expertise to healthcare enterprises.

Ludovic Alonzi· Partner· Lyon, Auvergne-Rhône-Alpes, Francein

Ludovic Alonzi is a Partner at ARCHIMED, a global private equity firm specializing in healthcare sector investments across Europe and North America. He works within a multidisciplinary team that integrates investment, medical, scientific, and operational expertise to support healthcare enterprises.

Marcin Goszyk· Partner· Lyon, Auvergne-Rhône-Alpes, Francein

Marcin Goszyk is a Partner at ARCHIMED, a private equity firm focused on healthcare investments. He works with healthcare companies on global expansion and organizational development.

Rami Suzuki· Managing Director· Tokyo, Japanin

Robin Filmer-Wilson· Partner· London, England, United Kingdomin

Robin Filmer-Wilson is a Partner at ARCHIMED, a global private equity firm specializing in healthcare sector investments across Europe and North America. He serves as a Board Member at Corealis Pharma Inc. and brings investment, medical, scientific, and operational expertise to healthcare enterprise partnerships.

Sainath Ramanathan· Partner· Singaporein

Sainath Ramanathan is a Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America. He serves as a Board Member at Jeisys Medical and brings investment, medical, scientific, and operational expertise to healthcare enterprise partnerships.

Vincent Guillaumot· Managing Partner· Tokyo, Japanin

Vincent Guillaumot is Managing Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America. He serves as a Board Member at Stago and works with a team that combines investment, medical, scientific, and operational expertise to support healthcare enterprises.

Javier Martinez· Associate Director

Associate Director who completed a secondment to ARK Diagnostics, gaining operational experience alongside the management team.

Alex Martin· Associate· Georgetown, Prince Edward Island, Canadain

Associate with a medical background who built financial modelling skills through internal and external training and worked on two closed platform deals within the first year.

Cécile Pontier· Partner, Head of HR· New York, New York, United Statesin

Cécile Pontier is Head of Human Resources and Partner at ARCHIMED, a global private equity firm specializing in healthcare investments across Europe and North America.

Sandrine Laporte· Finance and Operations Partner· Francein

What they invest in

from 25 of 59 portfolio companies

Biotech ×18Healthtech ×18Medical Devices ×17Digital Health ×10Advanced Manufacturing ×5Deep Tech ×4AgTech ×2AI & Machine Learning ×2

HQs:United States×5Canada×3France×3United Kingdom×2Italy×2Spain×1

Investments · 59 tracked

founders shown can be your intro path

By year:2026 · 1 2014 · 23 dated

Cevaceva.com in 𝕏NASDAQ: CEVA✓ verified

Ceva is a global animal health company specializing in vaccines, reproductive management products, and behavioral control solutions for livestock and companion animals.

AgTechBiotechHealthtechLibourne, FR

Amir Panush(Chief Executive Officer and Director)Dr Marc Prikazsky(CEO)

Co-investorsMérieux Equity Partners Continental Grain Company EMZ Partners Mitsui & Co Sagard Temasek+1 more

Ametrisametris.com in

Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical Devices

Jeremy Wyatt in

Arkstonearkstone.ai in

Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Dave Gross(Co-Founder, Chief Technology Officer)inDr. Ari Frenkel(Co-Founder, Chief Science Officer)Sol Levi(Co-Founder, Chief Customer Officer)in Ian Campbell(CEO and Executive Chairman)in

Biovendor Groupbiovendor.group in

The company develops diagnostics and diagnostic solutions for laboratory technicians, physicians, and patients, prioritizing fast and reliable testing capabilities.

BiotechDigital HealthHealthtechMedical Devices

Cardiolinecardioline.com in

Cardioline develops diagnostic cardiology and telemedicine solutions, including ECG devices and telecardiology tools, for healthcare providers and clinicians.

Digital HealthHealthtechMedical Devices

Corealiscorealispharma.com in

Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies.

Advanced ManufacturingBiotechHealthtechMedical DevicesLaval, CA

David Leroux-Petersen(Chief Executive Officer)inPatrick Gosselin(Vice-President, Pharmaceutical R&D)Yves Mouget(Vice-President, Analytics)Pascal Tougas(Chief Financial Officer)in

Co-investorsLa Caisse

Cube Biotechcube-biotech.com in

Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels.

BiotechDeep TechNew Materials

Co-investorsCreathor Ventures

Diessediesse.it in 𝕏

Diesse develops and manufactures in-vitro diagnostic instruments and reagents for clinical laboratories, including automated ESR (erythrocyte sedimentation rate) analyzers, automated and manual immunoassay systems, and rapid diagnostic tests.

BiotechHealthtechMedical Devices

Esperion Therapeuticsesperion.comJun 2014

Biopharma developing HDL-C regulating therapies; listed 2000.

BiotechAnn Arbor, US

Antonio M. Gotto, Jr.(Director)Tim M. Mayleben(Executive Officer, Director)Gilbert S. Omenn(Director)Daniel Janney(Director)Dov A. Goldstein(Director)Roger S. Newton(Director)

Co-investorsAisling Capital Alta Partners Arboretum Ventures Asset Management Company Canaan Partners HealthCap +3 more

Eurolysereurolyser.com

EUROLyser develops diagnostic testing systems and parameters, including a beta-Hydroxybutyrate (BHB) test aimed at veterinarians for measuring ketone bodies.

HealthtechMedical Devices

Insteminstem.com in

Instem provides SaaS platforms and services for research and development in the life sciences industry, serving pharmaceutical companies, CROs, CDMOs, academic research institutions, biotechnology firms, industrial organizations, and agrichemical companies.

BiotechDigital HealthEnterprise SoftwareSaaSUnited Kingdom, GB

Natus Sensorynatussensory.com in

Natus Sensory develops medical devices and solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and sensory nervous systems.

Digital HealthHardwareHealthtechMedical Devices

Peter(Chief Executive Officer)

BoardMatthias(Executive Chairman of the Board)

Plasmid Factoryplasmidfactory.com

PlasmidFactory is a contract development and manufacturing organization (CDMO) that produces plasmid DNA and proprietary Minicircle DNA for research, preclinical, and GMP applications in gene and cell therapy, viral vectors, and vaccine development.

Advanced ManufacturingBiotechMedical Devices

Polypluspolyplus-sartorius.com in

Polyplus (a Sartorius company) develops FectoVIR-LV, an animal-component-free transfection reagent for producing lentiviral vectors in suspension HEK-293 cells at large manufacturing scale.

Advanced ManufacturingBiotechDeep TechHealthtechMedical Devices

Co-investorsWarburg Pincus

Prolleniumprollenium.com in 𝕏

Prollenium is a manufacturer of aesthetic and skin health products, offering end-to-end product development and manufacturing at a single North American location.

Advanced ManufacturingMedical DevicesWellness & FitnessRichmond Hill, CA

Provepharmprovepharm.com in

Provepharm is a pharmaceutical company specializing in health-related dyes and colorants, committed to sustainable development and providing quality information on health products to medical professionals.

BiotechHealthtechMedical DevicesMarseille, FR

Michel Feraud(Founder & CEO)inChristophe Baralotto(Founder)in

Renata Medicalrenatamedical.com inAug 2026 · $25M

Renata Medical develops and commercializes medical devices for unmet pediatric needs, with a focus on transcatheter implants and delivery systems such as stents for treating congenital heart defects in newborns and children.

BiotechHardwareHealthtechMedical DevicesCosta Mesa, US

Dr. Zahn(Chief Medical Officer)Dustin Armer(Founder)inEASON ABBOTT(Co-founder & COO)

Seqcenterseqcenter.com in 𝕏

SeqCenter provides DNA sequencing services with an emphasis on data security and biosecurity for research organizations.

AgTechBiotechCybersecurityData & InfrastructureDeep TechHealthtechPittsburgh, US

Dan Snyder(Founder)in

Stagostago.com in

Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsLa Caisse

Suanfarmasuanfarma.com in 𝕏

Suanfarma develops, manufactures, and distributes active pharmaceutical ingredients (APIs) for the global pharmaceutical industry, serving over 400 customers across 70+ countries.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtech

Theactigraphtheactigraph.com in

Ametris provides wearable digital health technology devices and remote monitoring platforms for clinical trials and pharmaceutical research.

Digital HealthHealthtechMedical DevicesAtlanta, US

Title21 Health Solutionstitle21.com in 𝕏

Title21 provides software solutions for cellular therapy and biopharmaceutical manufacturing organizations, offering digital tools for patient coordination, manufacturing workflows, quality management, and regulatory compliance.

BiotechHealthtechMedical DevicesSaaS

Tony Pare in

Vita Health Groupvitahealthgroup.co.uk in 𝕏

Vita Health Group delivers patient-focused healthcare services with a commitment to sustainability and social value.

Digital HealthHealthtechImpact & Social GoodMental HealthWellness & Fitness

Zimviezimvie.com in 𝕏

ZimVie provides dental implant solutions, including full-arch immediate load implant systems, designed to improve patient smiles, function, and confidence.

BiotechDigital HealthMedical Devices

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ActiAd TechAliriArk DiagnosticsBiodextrisBOMIBomi GroupCarsoCellese CompanyCeva Animal HealthClean BiologicsClean Biologics Ex Clean CellsDeallusDermapharmDirect Healthcare Group%Ef%Bf%BcExcellgeneFim MedicalFytexiaGroupe Laboratoire RivadisIrabIrrimaxJeysisMicromedNamsaNatural OriginsNatus NeuroPrimo GroupPyxant LabsSmgStragenSymbioTitle21WiqoXpress BiologicsZytomics

Exits · 1

1 IPOs

CevaNASDAQ: CEVA

Fund performance · per public LP disclosures · 2

as of Sep 2025

Fund	Vintage	Committed	Net IRR	TVPI	DPI
ArchiMed Med RiseLPs: Orange County Employees Retirement System	2024	—	—	0.50x	—
ArchiMed MED Platform IILPs: Orange County Employees Retirement System	2022	—	21.6%	1.30x	0.01x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

How many investments has ARCHIMED Japan made?: ARCHIMED Japan has 59 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does ARCHIMED Japan invest at?: ARCHIMED Japan invests at the Growth, Late Stage stages.
What is ARCHIMED Japan's typical check size?: ARCHIMED Japan typically writes checks of $10.8M – $1.1B.
What sectors does ARCHIMED Japan focus on?: ARCHIMED Japan focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic, Wellness & Fitness.
Where is ARCHIMED Japan located?: ARCHIMED Japan is headquartered in Lyon, FR.
Does ARCHIMED Japan lead rounds?: Yes, ARCHIMED Japan leads investment rounds.
Who does ARCHIMED Japan co-invest with?: ARCHIMED Japan most often shares deals with Arboretum Ventures, Asset Management Company, Canaan Partners, among 9 tracked co-investors.

Similar investors

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.

$100K – $20M

Gore Range Capital

Gore Range Capital is a specialized healthcare investment firm building science-led platforms across precision health, regenerative medicine, personalized therapeutics, and longevity. It provides strategic, financial, and clinical guidance to portfolio companies developing next-generation healthcare solutions.

$500K – $5M

Portfolia

Portfolia operates thematic venture funds designed by and for women investors, backing companies in women's health, active aging, and longevity, alongside a community of over 2,200 women investors across 48 states and 20 countries.

$10K

Mammoth Research

Mammoth is a venture capital firm investing in health science and technology companies at Series A and beyond, with particular strength in navigating complex regulatory environments.